DOACs use in extreme body-weighted patients: results from the prospective START-register

M Guarascio, L Bertù, MP Donadini… - Internal and Emergency …, 2023 - Springer
Abstract Background Direct oral anticoagulants (DOACs) are widely used for the treatment of
venous thromboembolism (VTE) and for stroke prevention in atrial fibrillation (AF). However …
被引用次数：3 相关文章

DOACs use in extreme body-weighted patients: results from the prospective START-register.

M Guarascio, L Bertù, MP Donadini… - Internal and …, 2023 - europepmc.org
Background Direct oral anticoagulants (DOACs) are widely used for the treatment of venous
thromboembolism (VTE) and for stroke prevention in atrial fibrillation (AF). However …

DOACs use in extreme body-weighted patients: results from the prospective START-register

M Guarascio, L Bertù, MP Donadini… - INTERNAL AND …, 2023 - irinsubria.uninsubria.it
Background: Direct oral anticoagulants (DOACs) are widely used for the treatment of venous
thromboembolism (VTE) and for stroke prevention in atrial fibrillation (AF). However …

DOACs use in extreme body-weighted patients: results from the prospective START-register

M Guarascio, L Bertù, MP Donadini… - Internal and …, 2023 - pubmed.ncbi.nlm.nih.gov
Background Direct oral anticoagulants (DOACs) are widely used for the treatment of venous
thromboembolism (VTE) and for stroke prevention in atrial fibrillation (AF). However …